| Application no. and date | 11186901.2 (espacenet) (Federated) (European Patent Register), 20070628 | | Patent/reg. no. and date | DK/EP 2426150, 20171025 | | Publication date | 20120307 | | Priority no. and date | EP 06116429, 20060630 | | EP pub. no. and date |
EP 2426150 20120307 | | Effective date | | | Applicant/owner | Novo Nordisk A/S, Novo Allé 1, 2880 Bagsværd, DK | | Applicant ref. no. | INN NN7448EP2 | | Inventor | Spee, Pieter, Novo Nordisk A/S
Novo Allé, 2880 Bagsværd, DK,
Padkjær, Søren Berg, Novo Nordisk A/S
Novo Allé, 2880 Bagsværd, DK | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 31/12 (2006.01) , A61P 35/00 (2006.01) , A61P 37/00 (2006.01) , C07K 16/28 (2006.01) , C07K 16/46 (2006.01) | | Title | ANTI-NKG2A-ANTISTOFFER OG ANVENDELSER DERAF | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
